Clinical Center of Biotherapy at Zhongshan Hospital
Yunyu Mao has not added Biography.
If you are Yunyu Mao and would like to personalize this page please email our Author Liaison for assistance.
Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
Immunotherapy Feb, 2021 | Pubmed ID: 33225803
Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing.
Biomarker research Oct, 2020 | Pubmed ID: 33292642
PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.
Biomarker research Nov, 2020 | Pubmed ID: 33292688
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.
Cell discovery May, 2024 | Pubmed ID: 38740803
Fudan University
Ying Xue*,1,
Yunyu Mao*,2,
Qibin Liao3,
Chen Zhao4,
Xiaoyan Zhang1,2,4,
Jianqing Xu1,2,4
1Institutes of Biomedical Sciences, Fudan University,
2Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University,
3Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology,
4Shanghai Public Health Clinical Center, Fudan University
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены